Targeting myeloid cells to improve cancer immune therapy

Tumor immunosuppression remains a major barrier to effective cancer immunotherapy and is often driven by the immunoregulatory activities of innate immune cells, such as myeloid cells within the tumor microenvironment (TME). Myeloid populations—including tumor-associated macrophages (TAMs), dendritic...

詳細記述

書誌詳細

出版年:	Frontiers in Immunology
主要な著者:	Hui Chen, Zihan Xu, Judith Varner
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2025-07-01
主題:	myeloid cell tumor associated macrophage (TAM) PI3Kgamma TREM2 CSF1R (colony stimulating factor 1 receptor) Axl
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1623436/full